Core Viewpoint - A product claiming to be "99% pure Antarctic krill oil" from "Beijing Tongrentang" was found to contain "0" krill oil, raising concerns about misleading marketing practices and consumer protection [1][3][12]. Group 1: Product Misrepresentation - The Shanghai Consumer Protection Commission tested 15 popular Antarctic krill oil products and discovered that the product in question had no actual krill oil content, despite claims of 43% phospholipid content [1][3]. - The manufacturer, Anhui Habao Pharmaceutical Co., admitted that the product was customized by the distributor, Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., and did not contain the claimed krill oil [4][8]. - The product was sold at a price of 60 yuan per bottle, while the manufacturer's cost was only 3 to 3.7 yuan, raising questions about the legitimacy of the pricing and the quality of the ingredients [4][11]. Group 2: Misleading Branding - The packaging prominently featured "Beijing Tongrentang," which misled consumers into believing it was a product directly from the well-known brand, while it was actually from a different company [4][7]. - The product's branding utilized a design that closely resembled the core trademark of Beijing Tongrentang, creating a deceptive impression of authenticity [7][19]. - The distributor claimed that misleading packaging decisions were made by the manufacturer, while the manufacturer stated that the packaging was designed according to the distributor's specifications, indicating a shared responsibility for the misleading marketing [8][11]. Group 3: Broader Industry Implications - The incident is not isolated; there is a larger trend of "borderline" products using the Tongrentang name to mislead consumers, with similar products also found on e-commerce platforms [12][18]. - The Shanghai Consumer Protection Commission urged the distributor to conduct a self-examination, apologize to consumers, and recall the problematic products [19][20]. - Beijing Tongrentang Health Pharmaceutical Co. announced that it would stop the distribution of the implicated product and initiate legal action against the responsible parties for unauthorized use of its name [19][20].